Arcellx
在场
是其中之一......
Arcellx 是一家在股票代码 ACLX (US) 下上市的公司。
涉及Arcellx的并购和融资。
- Arcellx 刚刚宣布为 225 筹款数百万美元。 (公布2022十二月14号).
高管
查看带有其 20 名主要高管的组织结构图
Arcellx 搜索最多的简介
- Rami Elghandour, Chief Executive Officer and Chairman of the Board
- Derek Yoon, Director
- Kavita Gupta, Board Member
创建提醒
跟踪 Arcellx 的高管变动
生物技术
Arcellx 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Arcellx 的最新新闻稿
- Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
- Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study
- Arcellx Provides Second Quarter 2024 Financial Results and Business Updates
- Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
- Arcellx Provides First Quarter 2024 Financial Results
- Arcellx to Participate in Two Upcoming Investor Conferences
- Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
- Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
- Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
- View more press releases Close
关于 Arcellx 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Rami Elghandour 
